Naoto Tamura

The soluble CD40 ligand sCD154 in systemic lupus erythematosus

Kazunori Kato, Ernesto Santana-Sahagún, Laura Z. Rassenti et al. · Journal of Clinical Investigation · 1999 · 197 citations · Full text

Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety

Yukiko Komano, Michi Tanaka, Toshihiro Nanki et al. · The Journal of Rheumatology · 2011 · 157 citations · Full text

Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study

Yoshikazu Nakaoka, Mitsuaki Isobe, Yoshiya Tanaka et al. · Lara D. Veeken · 2019 · 111 citations · Full text

Clinical characteristics and change in the antibody titres of patients with anti-MDA5 antibody–positive inflammatory myositis

Yoshiyuki Abe, Masakazu Matsushita, Kurisu Tada et al. · Lara D. Veeken · 2017 · 108 citations · Full text

Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus

Asako Chiba, Naoto Tamura, Kazunori Yoshikiyo et al. · Arthritis Research & Therapy · 2017 · 104 citations · Full text